Adherium Expands Its International Presence, Announces Senior Appointment
23 Feb 2017
Adherium Limited (ASX : ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today announced the appointment of a new Vice President of Business Development for its key markets outside of North America and Europe.
Erin Wansbrough will lead Adherium’s partnering and market expansion for the ‘Rest of World’ territories, including Asia Pacific and the Middle East where Adherium already has approvals to market its SmartinhalerTM products in China, Australia and New Zealand. Erin will be operating out of the Company’s existing Asia Pacific base in Auckland, New Zealand.
Ms Wansbrough joins Adherium after a successful career over the last 16 years that spans multiple industries including pharmaceuticals, healthcare, biotechnology, and ICT across both private and public sectors. As a senior professional, Erin has a strong track record with innovative, high-growth companies.
Erin began her career with Life Technologies in New Zealand in Product and Sales Management. She then went on to work for AstraZeneca and GSK in a Sales Management capacity before joining Genesis Research & Development Corporation as Business Development Manager.
Erin is currently a Director of the New Zealand Technology Industry Association (NZTech) and joins Adherium from Callaghan Innovation where she was responsible for building the Business Innovation Group.
Prior to this, Erin spent a period of time in Australia as Business Development Manager with IMBcom, a private company dedicated to the commercialisation of research from one of the leading biotechnology research organisations in Australia, The University of Queensland.
Garth Sutherland, Group CEO of Adherium said:
“I am delighted to welcome Erin to Adherium’s growing global Business Development team. This is a key milestone for us as we continue to build our commercial capabilities to attract and service new customers. Erin has a proven track record of executing commercial partnerships and business development management."
Erin Wansbrough added:
“It’s been exciting to watch the progress of the company over the last few years and it will be a privilege to join the team to help build Adherium’s future. Fulfilling the promise of empowering people with chronic conditions to live the life they want.”
Click here to download the full press release.